Purple Biotech (PPBT) Other Working Capital Changes (2019 - 2026)
Purple Biotech's (PPBT) quarterly Other Working Capital Changes came in at -$59000.0 in Q1 2026, down 11.32% year-on-year from -$66531.9 in Q1 2025, and up 3.28% on a QoQ basis from -$61000.0 in Q4 2025.
Purple Biotech (PPBT) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 8 years of Other Working Capital Changes data on file, last reported at -$59000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 11.32% year-over-year to -$59000.0 in Q1 2026; TTM through Mar 2026 was -$223000.0, a 16.75% decrease from a year earlier, with the FY2025 full-year figure at -$217000.0, down 18.58% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$59000.0, up from -$61000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for PPBT reached as high as $848000.0 in Q2 2022 and fell as low as -$1.1 million in Q1 2022.
- Historically, Other Working Capital Changes has averaged $38764.7 across 5 years, with a median of $71000.0 in 2025.
- Across the five-year window, Other Working Capital Changes surged 48.75% in 2022 and sank 45.45% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$41000.0 in 2022, then fell by 2.44% to -$42000.0 in 2023, then dropped by 14.29% to -$48000.0 in 2024, then slipped by 27.08% to -$61000.0 in 2025, then grew by 3.28% to -$59000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$59000.0 in Q1 2026, -$61000.0 in Q4 2025, and -$64000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59,000.00 |
| Mar 31, 2026 | -59,000.00 |
| Mar 31, 2026 | -59,000.00 |
| Dec 31, 2025 | -61,000.00 |
| Dec 31, 2025 | -61,000.00 |
| Dec 31, 2025 | -61,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | -53,000.00 |
| Mar 31, 2025 | -53,000.00 |
| Mar 31, 2025 | -53,000.00 |
| Dec 31, 2024 | -48,000.00 |
| Dec 31, 2024 | -48,000.00 |
| Dec 31, 2024 | -48,000.00 |
| Sep 30, 2024 | -44,000.00 |
| Sep 30, 2024 | -44,000.00 |